CTLA4 and colon adenocarcinoma: CTLA-4 ICB in preclinical murine models of colon adenocarcinoma significantly decreased tumour growth, increased the frequency of tumour-infiltrating effector T cells and selectively depleted intra-tumoural regulatory T cells [29].